Showing 952 results

Filters Content type: News, Editors' picks, About HIV Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Side effects

PrEP in pregnancy: safe, but many unanswered questions

News
7 February 2020
Weight gain & lipodystrophy

TreatmentUpdate: weight gain

Editor's pick
CATIE
28 January 2020
PrEP policies & guidelines

Truvada, not Descovy, should be the first choice for PrEP, US experts say

News
14 January 2020
Weight gain & lipodystrophy

What we know about Descovy’s impact on weight & cholesterol

Editor's pick
San Francisco AIDS Foundation
9 January 2020
Bad science & bogus treatments

Facebook disables some misleading ads on HIV prevention drugs, responding to growing outcry

Editor's pick
Washington Post
2 January 2020
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
Changing treatment

Lipid increases after switching from TDF to TAF are reversible when treatment is changed back to TDF

News
10 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019
Changing treatment

Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir

Editor's pick
Spotlight
25 November 2019
PrEP science

96-week results of DISCOVER PrEP trial presented at European AIDS Conference

News
14 November 2019
Kidney problems

Tenofovir (TDF) does not increase risk of kidney disease in people at low risk

News
13 November 2019
Weight gain & lipodystrophy

Dolutegravir and raltegravir cause changes to fat cells

News
11 November 2019
Side effects

Weight gain after switching to integrase inhibitor treatment is small in Dutch and Swiss cohorts

News
11 November 2019
Side effects

ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF

News
8 November 2019
Side effects

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause

News
8 November 2019
Bad science & bogus treatments

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Editor's pick
TheBodyPro
7 November 2019
Side effects

Updated Labeling for Efavirenz-Containing Products Warns of Possible Late-Onset Neurotoxicity

Editor's pick
Monthly Prescribing Reference
31 October 2019
Starting treatment

Weight gain on HIV treatment: more common with newer drugs, low CD4 counts

News
31 October 2019
Reproductive health

Women with HIV not at higher risk of blood pressure disorders in pregnancy

News
30 October 2019
PrEP science

Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?

News
15 October 2019
Side effects

Do integrase inhibitors increase the risk of diabetes?

News
7 October 2019
Side effects

Switching From TDF to TAF-Containing ART Carries BMI, Atherosclerotic Cardiovascular Disease Risk

Editor's pick
Contagion Live
7 October 2019
Side effects

Unsure whether I'll join Gilead lawsuit

Editor's pick
Bay Area Reporter
27 September 2019
Cardiovascular disease

Switching Back to Older Tenofovir Improves Lipid Levels

Editor's pick
POZ
12 September 2019